Cargando…

Multidisciplinary care for patients with HCC: a systematic review and meta-analysis

Given the complexity of managing HCC, professional society guidelines advocate multidisciplinary care (MDC) for patients with HCC. However, implementation of MDC programs requires a significant investment of time and resources. We conducted a systematic review and meta-analysis to enumerate potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seif El Dahan, Karim, Reczek, Annika, Daher, Darine, Rich, Nicole E., Yang, Ju Dong, Hsiehchen, David, Zhu, Hao, Patel, Madhukar S., Bayona Molano, Maria del Pilar, Sanford, Nina, Gopal, Purva, Parikh, Neehar D., Yopp, Adam C., Singal, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146543/ https://www.ncbi.nlm.nih.gov/pubmed/37102768 http://dx.doi.org/10.1097/HC9.0000000000000143

Ejemplares similares

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
por: Cabrera, Roniel, et al.
Publicado: (2020)

Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

A Dual‐Filtration System for Single‐Cell Sequencing of Circulating Tumor Cells and Clusters in HCC
por: Chen, Vincent L., et al.
Publicado: (2022)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Emergent mechanical thrombectomy for right atrial clot and massive pulmonary embolism using flowtriever
por: Bayona Molano, Maria del Pilar, et al.
Publicado: (2021)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging
por: Yokoo, Takeshi, et al.
Publicado: (2017)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022)

Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort
por: Kopplin, Noa, et al.
Publicado: (2023)

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling
por: Choi, Eunhee, et al.
Publicado: (2019)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
por: Brown, Andrew M., et al.
Publicado: (2022)

Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
por: Singal, Amit G, et al.
Publicado: (2016)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
por: Tapper, Elliot B, et al.
Publicado: (2018)

Integrated Multidisciplinary Management of Alcohol-associated Liver Disease
por: Holbeck, Malia, et al.
Publicado: (2023)

Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
por: Reeves, Helen L, et al.
Publicado: (2022)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

A Multidisciplinary Aesthetic Treatment Approach for Peg Lateral of the Maxillary Incisors
por: Rathi, Shruti, et al.
Publicado: (2022)

Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study
por: Singal, Amit G., et al.
Publicado: (2023)

Knowledge and attitudes of medical students in Lebanon toward artificial intelligence: A national survey study
por: Doumat, George, et al.
Publicado: (2022)

Congenital intrahepatic portosystemic venous shunt embolization: A two‐case experience
por: Bayona Molano, Maria del Pilar, et al.
Publicado: (2020)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Mini-ALPPS-based multidisciplinary treatment leading to long-term survival in a patient with a large HCC: A case report
por: Liu, Gao-Min, et al.
Publicado: (2023)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study
por: Moon, Andrew M., et al.
Publicado: (2023)

HCC surveillance results in earlier HCC detection: results from an Indian cohort
por: Kohli, Anita, et al.
Publicado: (2014)

Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
por: Llovet, Josep M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b62q7cn95uhvrkmhj00783s93c